Li Min Ling

530 total citations
10 papers, 231 citations indexed

About

Li Min Ling is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Oncology. According to data from OpenAlex, Li Min Ling has authored 10 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Applied Microbiology and Biotechnology and 3 papers in Oncology. Recurrent topics in Li Min Ling's work include Antibiotic Use and Resistance (4 papers), Patient Satisfaction in Healthcare (2 papers) and COVID-19 Clinical Research Studies (2 papers). Li Min Ling is often cited by papers focused on Antibiotic Use and Resistance (4 papers), Patient Satisfaction in Healthcare (2 papers) and COVID-19 Clinical Research Studies (2 papers). Li Min Ling collaborates with scholars based in Singapore, Taiwan and Australia. Li Min Ling's co-authors include Tat Ming Ng, David Chien Lye, Christine B. Teng, Brenda Ang, Sock Hoon Tan, Karin Thursky, Jeff Szer, C. O. Morrissey, Monica A. Slavin and Christopher H. Heath and has published in prestigious journals such as Journal of Chromatography A, Journal of Antimicrobial Chemotherapy and Vaccine.

In The Last Decade

Li Min Ling

10 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Min Ling Singapore 7 100 90 67 43 40 10 231
Merel M. C. Lambregts Netherlands 10 82 0.8× 68 0.8× 151 2.3× 44 1.0× 28 0.7× 28 307
Vanesa Antón-Vázquez United Kingdom 10 134 1.3× 47 0.5× 99 1.5× 49 1.1× 62 1.6× 29 297
Zaira R. Palacios‐Baena Spain 9 76 0.8× 75 0.8× 65 1.0× 15 0.3× 108 2.7× 28 262
Luis Escosa‐García Spain 8 72 0.7× 64 0.7× 79 1.2× 33 0.8× 86 2.1× 34 230
Nour Shbaklo Italy 10 60 0.6× 83 0.9× 91 1.4× 13 0.3× 86 2.1× 30 250
Elizabeth Dodds‐Ashley United States 7 50 0.5× 88 1.0× 106 1.6× 10 0.2× 24 0.6× 9 198
David Aguilera‐Alonso Spain 9 55 0.6× 61 0.7× 79 1.2× 29 0.7× 78 1.9× 43 253
Morgan Matt France 9 38 0.4× 85 0.9× 59 0.9× 20 0.5× 40 1.0× 20 214
Maia De Luca Italy 10 54 0.5× 75 0.8× 201 3.0× 100 2.3× 34 0.8× 39 361
Mercedes Palomar Martínez Spain 9 53 0.5× 63 0.7× 87 1.3× 19 0.4× 36 0.9× 31 230

Countries citing papers authored by Li Min Ling

Since Specialization
Citations

This map shows the geographic impact of Li Min Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Min Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Min Ling more than expected).

Fields of papers citing papers by Li Min Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Min Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Min Ling. The network helps show where Li Min Ling may publish in the future.

Co-authorship network of co-authors of Li Min Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Li Min Ling. A scholar is included among the top collaborators of Li Min Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Min Ling. Li Min Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Jiangang, Li Min Ling, Siyuan Liang, et al.. (2025). Simultaneous determination of 12 lipophilic shellfish toxins in human plasma, serum, and urine using UPLC–MS/MS combined with PRiME HLB μElution platform. Journal of Chromatography A. 1762. 466418–466418. 1 indexed citations
2.
Fan, Bingwen Eugene, Jensen Ng, Stephrene Seok Wei Chan, et al.. (2020). COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. Journal of Thrombosis and Thrombolysis. 51(3). 663–674. 40 indexed citations
3.
Lee, Jinhyun, et al.. (2020). Cardiac Catheterisation for ST-Elevation Myocardial Infarction During COVID-19 in Singapore: Protocols and Recommendations. Annals of the Academy of Medicine Singapore. 49(8). 600–604. 2 indexed citations
5.
Ng, Tat Ming, Barnaby Edward Young, Sock Hoon Tan, et al.. (2017). Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team. International Journal of Antimicrobial Agents. 50(2). 166–170. 8 indexed citations
6.
Teng, Christine B., Tat Ming Ng, Sock Hoon Tan, et al.. (2015). Safety and Effectiveness of Improving Carbapenem Use via Prospective Review and Feedback in a Multidisciplinary Antimicrobial Stewardship Programme. Annals of the Academy of Medicine Singapore. 44(1). 19–25. 22 indexed citations
7.
Chow, Angela, Tat Ming Ng, Christine B. Teng, et al.. (2015). Implementation hurdles of an interactive, integrated, point-of-care computerised decision support system for hospital antibiotic prescription. International Journal of Antimicrobial Agents. 47(2). 132–139. 24 indexed citations
8.
Ng, Tat Ming, Sock Hoon Tan, Li Min Ling, et al.. (2014). Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting. Journal of Antimicrobial Chemotherapy. 70(4). 1219–1225. 65 indexed citations
9.
Slavin, Monica A., Christopher H. Heath, Karin Thursky, et al.. (2008). Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Internal Medicine Journal. 38(6b). 468–476. 28 indexed citations
10.
Ling, Li Min. (2003). Analysis of Cancer Incidence in Urban Beijing During 1993-1997. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026